Both in Pharmaceuticals
Cartesian Therapeutics vs Entrada Therapeutics
Over the past year RNAC returned −35.7% and TRDA returned −30.1%; their daily moves had a correlation of 0.20.
RNAC −35.7% TRDA −30.1%Growth of $1, one year, split-adjusted
| Metric | RNAC | TRDA |
|---|---|---|
| Price | $6.27 | $4.37 |
| Market cap | $189.7M | $170.2M |
| Today | −4.71% | −8.58% |
| 1 month | −20.2% | −36.7% |
| 6 months | −10.9% | −68.8% |
| Year to date | −13.0% | −57.5% |
| 1 year | −35.0% | −29.4% |
| Revenue growth (YoY) | −100.0% | −53.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −4762.0% |
| P/E (TTM) | — | — |
| Price / sales | 128.4× | 36.3× |
| Net cash | $94.8M | $223.0M |
| Dividend yield | — | — |
| Volatility (60d) | 48.5% | 72.7% |
| Short % of float | 15.4% | 11.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).